-
Cancer Anorexia-Cachexia Syndrome Disease - Global Clinical Trials Review, H2, 2020
Published: November, 2020 - Pages: 104 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Small Intestine Cancer Disease - Global Clinical Trials Review H2 2020
Published: December, 2020 - Pages: 140 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Vulvar Cancer Disease - Global Clinical Trials Review, H2, 2020
Published: December, 2020 - Pages: 117 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Hypopharyngeal Cancer Disease - Global Clinical Trials Review, H2, 2020
Published: December, 2020 - Pages: 341 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Recurrent Head And Neck Cancer Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2018
Published: June, 2018 - Pages: 258 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Endometrial Cancer Global Clinical Trials Review, H2, 2020
Published: August, 2020 - Pages: 616 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Salivary Gland Cancer Global Clinical Trials Review, H2, 2020
Published: August, 2020 - Pages: 175 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Gallbladder Cancer Global Clinical Trials Review, H2, 2020
Published: August, 2020 - Pages: 273 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Oropharyngeal Cancer Global Clinical Trials Review, H2, 2020
Published: September, 2020 - Pages: 448 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Nasopharyngeal Cancer Global Clinical Trials Review, H2, 2020
Published: September, 2020 - Pages: 433 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2024
Published: July, 2018 - Pages: 152 - US$ 4,995.00
COVID-19 update included[CovidUpdated]
-
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024
Published: May, 2018 - Pages: 215 - US$ 4,995.00
COVID-19 update included[CovidUpdated]
-
Head and Neck Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Immunotherapies and Increasing Pre...
Published: December, 2017 - Pages: 155 - US$ 4,995.00
COVID-19 update included[CovidUpdated]
-
Breast Cancer Therapeutics in Southeast Asia Markets to 2022
Published: April, 2017 - Pages: 176 - US$ 4,995.00
COVID-19 update included[CovidUpdated]
-
Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Incre...
Published: March, 2017 - Pages: 161 - US$ 4,995.00
COVID-19 update included[CovidUpdated]
-
Non-Small Cell Lung Cancer (NSCLC) - China Drug Forecast and Market Analysis to 2025
Published: November, 2016 - Pages: 478 - US$ 4,995.00
COVID-19 update included[CovidUpdated]
-
Non-Small Cell Lung Cancer (NSCLC) - Japan Drug Forecast and Market Analysis to 2025
Published: November, 2016 - Pages: 478 - US$ 4,995.00
COVID-19 update included[CovidUpdated]
-
Non-Small Cell Lung Cancer (NSCLC) - US Drug Forecast and Market Analysis to 2025
Published: November, 2016 - Pages: 479 - US$ 4,995.00
COVID-19 update included[CovidUpdated]
-
Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biolog...
Published: February, 2016 - Pages: 171 - US$ 4,995.00
COVID-19 update included[CovidUpdated]
-
Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New ...
Published: January, 2015 - Pages: 126 - US$ 4,995.00
COVID-19 update included[CovidUpdated]
US $
Euro €
GBP £